ELVN
Enliven Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$59.32
−0.55%Jun 15, 2026, 20:40 UTC
Enliven Therapeutics closed an upsized underwritten public offering of common stock and pre-funded warrants, including full exercise of the underwriters' option to purchase additional shares.
Source:Jun 11, 2026, 20:05 UTC
Enliven Therapeutics commenced an underwritten public offering of $250.0 million of shares of its common stock and pre-funded warrants.
Source: